Icahn, after break from biopharma activism, hires Harvard geneticist Richard Mulligan By: Top News and Analysis (pro) March 01, 2017 at 09:50 AM EST The hire signals Carl Icahn may be back, at a time when biotech valuations are 25 percent off their 2015 highs. Read More >>